This is incredibly accurate. I read through this, thinking “No, I don’t see my role on here at all” — and then there it was. The Professor role describes me precisely.
I wonder what the proportion is of writers in each category? Is one category dominating the number of stories written?
Hi Stephen, I’ve already added this article to The Startup, a different publication — but if you want to add me as an approved submitter, I will consider Age of Awareness for my next article.
Totally true! I suppose, then, the only way to have an investment be truly, truly passive is if you set up an automatic recurring transfer to a stable investment portfolio.
And even that takes a bit of work, at least initially!
Yes, sex counts as genetics, but it’s often treated as its own variable (in part because it’s readily observable and is a true/false differentiator, instead of requiring a genetic test and having more of an additive effect).
In regards to burning visceral fat first, this doesn’t happen in all cases, but is generally regarded…
Interestingly, there are capsules that contain human microbiomes, taken directly from the guts of healthy donors (and I could probably write a whole article on the fascinating process of selecting fecal donors!), but they generally aren’t available over-the-counter.
This is incorrect in two different ways.
Nickel is a micronutrient — our bodies do need trace amounts of this mineral.
Additionally, nickel is removed from the body through urination or excretion — it’s filtered out.
This article needs a fact check.
Sure, I’d be happy to join as a writer. I believe that you can add me as a writer to the publication, and get a notification when I submit an article for you (as editor) to review and approve.
I’m happy to submit any posts that I think would fit the publication, especially those related to climate change and environmental issues.
This is a good consideration, and I think that these plant-based substitutes show some promise — but it’s still uncertain what savings of resources comes from them.
Finless foods, for example, talks about sourcing high-quality fish cells, which it cultures and grows into a food product. This eliminates the need for a fishing…
You are correct, and the procedure itself — for C. difficile treatment — hasn’t been blocked. However, ongoing clinical trials, which typically involve higher-risk patients, have been halted. For potential recipients who are not part of a clinical trial, there is a safety alert issued, but the treatment itself is not completely blocked.